Verrica Pharmaceuticals (VRCA) Capital Leases (2021 - 2026)
Verrica Pharmaceuticals (VRCA) posted quarterly Capital Leases of $546000.0 for Q1 2026, down 16.64% year-over-year from $655000.0 in Q1 2025, and down 15.09% quarter-over-quarter from $643000.0 in Q4 2025.
Verrica Pharmaceuticals (VRCA) Capital Leases (2021 - 2026) Analysis & Trends
Verrica Pharmaceuticals' Capital Leases history runs 6 years deep, the most recent figure standing at $546000.0 for Q1 2026.
- In Q1 2026, Capital Leases fell 16.64% year-over-year to $546000.0; the TTM figure through Mar 2026 stood at $546000.0 (down 16.64% YoY), while the FY2025 annual figure was $643000.0, down 16.28% from the prior year.
- Capital Leases for Q1 2026 stood at $546000.0, down from $643000.0 in the prior quarter.
- The five-year high for Capital Leases was $2.0 million in Q3 2024, with the low at $13000.0 in Q2 2022.
- The 5-year median for Capital Leases is $643000.0 (2025), against an average of $804769.2.
- The sharpest annual moves came in 2024 and 2025: Capital Leases jumped 2346.91% in 2024, then slumped 68.26% in 2025.
- Verrica Pharmaceuticals' Capital Leases stood at $13000.0 in 2022, then soared by 7792.31% to $1.0 million in 2023, then retreated by 25.15% to $768000.0 in 2024, then declined by 16.28% to $643000.0 in 2025, then decreased by 15.09% to $546000.0 in 2026.
- Business Quant data shows VRCA's Capital Leases at $546000.0 in Q1 2026, $643000.0 in Q4 2025, and $629000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Verrica Pharmaceuticals | 104.71 Mn | 93.51 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 793,000.00 |
| Mar 31, 2026 | 546,000.00 |
| Dec 31, 2025 | 643,000.00 |
| Sep 30, 2025 | 629,000.00 |
| Jun 30, 2025 | 579,000.00 |
| Mar 31, 2025 | 655,000.00 |
| Dec 31, 2024 | 768,000.00 |
| Sep 30, 2024 | 1.98 Mn |
| Jun 30, 2024 | 1.76 Mn |
| Mar 31, 2024 | 1.76 Mn |
| Dec 31, 2023 | 1.03 Mn |
| Sep 30, 2023 | 81,000.00 |
| Jun 30, 2022 | 13,000.00 |
| Mar 31, 2022 | 15,000.00 |
| Dec 31, 2021 | 16,000.00 |
| Sep 30, 2021 | 18,000.00 |
| Jun 30, 2021 | 19,000.00 |